Global Breast Lesion Localization Methods Market Size, Share, Growth & Trends Analysis Report By End User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers), Aftermarket) By Imaging Modality (Mammography, Ultrasound, Magnetic Resonance Imaging (MRI)) And Regional Outlook, Growth Potential & Forecast 2024 – 2030

Loading...

Summary of Report:

The Global Breast Lesion Localization Methods Market was worth USD 1.13 billion in 2024 and is expected to grow to USD 2.47billion by 2030, at a CAGR of 11.80% during the forecast period.

Price

Original price was: $3,999.00.Current price is: $2,999.00.
Original price was: $4,999.00.Current price is: $3,999.00.
Original price was: $9,999.00.Current price is: $8,999.00.

Do You have any Budget constraints?
Simply Ask our Sales Team About it.

Loading...

Description

Scope Breast Lesion Localization Methods Market

Breast Lesion Localization Methods Market covers a broad variety of localization techniques, including wire localization, electromagnetic seed localization (MSL), radioactive seed localization (RSL), ultrasound-guided localization, stereotactic localization, radiofrequency identification (RFID), and image-guided localization systems. These techniques make it easier to precisely identify and locate breast lesions, which helps with surgical excision or biopsy. The market may be divided into segments according to the localization technique, end-user (hospitals, diagnostic imaging centers, ambulatory surgical centers), imaging modality (such as mammography, ultrasound, and MRI), and geographic area. Market dynamics may be influenced by distinct growth patterns and variables for each segment.

The market’s worldwide reach encompasses areas like Latin America, North America, Europe, Asia Pacific, the Middle East, and Africa. Disparities in market size and growth rates are a result of regional disparities in the healthcare infrastructure, regulatory environment, payment practices, and prevalence of breast cancer. Both well-established medical device businesses and up-and-coming firms that prioritize breast lesion localization technology innovation define the market. Product creation, alliances, mergers and acquisitions, and geographic growth are examples of competitive tactics.

The Global Breast Lesion Localization Methods Market was worth USD 1.13 billion in 2024 and is expected to grow to USD 2.47billion by 2030, at a CAGR of 11.80% during the forecast period. The research looks at the market in terms of revenue in all of the key regions, which have been divided into countries.

Breast Lesion Localization Methods Market: Impact of COVID – 19

Many medical facilities delayed non-urgent treatments, such as diagnostic imaging and breast cancer screenings, during the peak of the epidemic. As a result, fewer breast lesion localization operations were carried out, which had an impact on the market for localization technology and equipment. 

The pandemic-related disturbances may cause delays in breast cancer detection and treatment, which might lead to the illness progressing to more advanced stages and requiring more severe surgical operations. This might affect the overall demand for breast lesion localization technology as well as the kind and frequency of localization techniques employed. It is possible that the pandemic’s effects on the worldwide supply chain, including production hold-ups and logistical difficulties, impacted the accessibility of localization tools and parts.

This could have affected how well medical institutions were able to carry out breast lesion localization operations. When in-person visits were few, the pandemic sped up the introduction of telemedicine and remote monitoring technology, allowing medical professionals to evaluate and track patients’ breast health from a distance. Although the need for breast lesion localization techniques may not be directly impacted by these technologies, patient care plans and referral trends may be.

Breast Lesion Localization Methods Market: Growth Drivers

  • Growing Incidence of Breast Cancer: The market for breast lesion localization techniques is significantly influenced by the growing incidence of breast cancer worldwide. Accurate localization techniques are becoming more and more important to support breast cancer detection and therapy as the disease’s incidence rises.
  • Technological Developments: The market is expanding due to ongoing developments in localization techniques and imaging technologies. Breast lesion localization methods are becoming more accurate and efficient thanks to innovations including image-guided localization systems, radiofrequency identification, and magnetic seed localization.
  • Trend toward Minimally Invasive Procedures: As a result of advantages including less pain for patients, better surgical results, and shorter hospital stays, minimally invasive localization procedures are becoming more and more popular than classic wire localization.

Breast Lesion Localization Methods Market: Restraints

  • Challenges with Reimbursement: In areas with stringent reimbursement policies, payment regulations and coverage restrictions for breast lesion localization procedures may provide difficulties for medical professionals and impede the uptake of specific technologies.
  • High Initial Cost: Certain modern technologies for localizing breast lesions may come with a high initial cost, which might restrict their use, especially in healthcare settings with limited resources.
  • Regulatory Obstacles: The market for breast lesion localization techniques is likely to remain stagnant due to the lengthy approval procedures and strict regulatory regulations that impede the entrance and commercialization of innovative medical devices.

Breast Lesion Localization Methods Market: Opportunity Factors

  • Developing Markets: As the need for cutting-edge medical technology and better healthcare infrastructure grows, there is a great deal of unrealized potential for breast lesion localization techniques in developing nations.
  • Emphasis on Solutions Relating to Patients: There are opportunities for enterprises to create patient-centric localization solutions, which put the needs and preferences of the patient first. By doing so, they may improve results and increase patient satisfaction.

Breast Lesion Localization Methods Market: Challenges

  • Technological Complexity: Resolving technical issues with software development, image integration, and device design is necessary to create and apply sophisticated breast lesion localization technologies. It will need a large investment in research and development to overcome these complications.
  • Regulatory Compliance: It might take a while and be difficult to comply with regulations in order to get new breast lesion localization devices approved. Businesses have to overcome regulatory obstacles, such as strict quality regulations and paperwork needs that might differ depending on the location.
  • Clinical Validation: Obtaining regulatory clearance and market adoption of novel breast lesion localization techniques requires proving their safety and effectiveness via thorough clinical trials. Large-scale clinical studies can take a lot of time and resources to conduct with the right outcomes.

Breast Lesion Localization Methods Market: Recent Developments

  • Hologic, Inc.: Hologic is renowned for its ongoing innovation in biopsy and breast imaging products. They may have updated their 3D mammography and breast biopsy technology, as well as made progress in their wire localization systems.
  • Cianna Medical: Cianna Medical specializes in radar localization systems that don’t require wires. Their SAVI SCOUT® system may have undergone recent upgrades that include enhanced accuracy, user-friendliness, and interaction with other imaging modalities.
  • Merit Medical Systems, Inc.: Merit Medical provides a wire-free navigation system called LOCalizerTM. Their product line may have grown recently, or they may have added new features to improve the functionality and efficiency of their localization system.

Breast Lesion Localization Methods Market: Key Outcomes of the Report

The market size of breast lesion localization methods as of right now and its anticipated growth over a certain time frame are going to be covered in the study. This would comprise projections, present trends, and historical data. It would go into depth on market segmentation according to end-user, geographic location, imaging modality, and localization technique.

Gaining insight into the market’s segmentation facilitates stakeholders’ identification of development prospects and efficient targeting of certain market groups. The competitive environment of the breast lesion localization techniques market, including major competitors, market shares, approaches, and new developments, will be examined in the study. This aids in the comprehension of competitive dynamics by stakeholders and the development of successful tactics.

List of Key Players in the Global Breast Lesion Localization Methods Market:

  • Hologic, Inc
  • Cianna Medical
  • Merit Medical Systems, Inc
  • Endomagnetics
  • Lumicell
  • Faxitron Bioptics
  • Cook Medical
  • I.C. Medical
  • Sanarus Technologies
  • Navigo Technology

Breast Lesion Localization Methods Market: Segmentation

By Localization Method

  • Wire Localization
  • Radioactive Seed Localization (RSL)
  • Magnetic Seed Localization (MSL)
  • Radiofrequency Identification (RFID)
  • Ultrasound-guided Localization
  • Stereotactic Localization 

By Imaging Modality

  • Mammography
  • Ultrasound
  • Magnetic Resonance Imaging (MRI)

By End-User

  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers

By Region

  • North America
  • Europe 
  • Asia Pacific 
  • Middle East and Africa 
  • Latin America 

Table of Content

1 Executive Summary
1.1 Introduction of Breast Lesion Localization Methods
1.2 COVID-19 Impacts on Breast Lesion Localization Methods Industry
2 Breast Lesion Localization Methods Market – Type Analysis
2.1 Global Breast Lesion Localization Methods Market – Type Overview
2.2 Global Breast Lesion Localization Methods Market Share, by Type, 2020 & 2029 (USD Million)
2.3 Wire Localization
2.03.01 Global Breast Lesion Localization Methods Market For Wire Localization, 2017 – 2027 (USD Million)
2.4 Radioisotope localization
2.04.01 Global Breast Lesion Localization Methods Market For Radioisotope localization, 2017 – 2027 (USD Million)
12.00.00 Magnetic localization
2.05.01 Global Breast Lesion Localization Methods Market For Magnetic localization, 2017 – 2027 (USD Million)
14.24.00 Others
2.06.01 Global Breast Lesion Localization Methods Market For Others, 2017 – 2027 (USD Million)
0.00.00 Breast Lesion Localization Methods Market – Usage Analysis
2.24.00 Global Breast Lesion Localization Methods Market – Usage Overview
4.48.00 Global Breast Lesion Localization Methods Market Share, by Usage, 2020 & 2029 (USD Million)
7.12.00 Tumor identification
3.03.01 Global Breast Lesion Localization Methods Market For Tumor identification, 2017 – 2027 (USD Million)
9.36.00 Sentinel lymph node identification
3.04.01 Global Sentinel lymph node identification Breast Lesion Localization Methods Market, 2017 – 2027 (USD Million)
0.00.00 Breast Lesion Localization Methods Market – Regional Analysis
2.24.00 Global Breast Lesion Localization Methods Market Regional Overview
4.48.00 Global Breast Lesion Localization Methods Market Share, by Region, 2020 & 2029 (USD Million)
7.12.00 North America
4.03.01 North America Breast Lesion Localization Methods Market, 2017 – 2027 (USD Million)
4.03.02 North America Breast Lesion Localization Methods Market, by Country, 2017 – 2027 (USD Million)
4.03.03 North America Breast Lesion Localization Methods Market, by Type, 2017 – 2027
4.03.04 North America Breast Lesion Localization Methods Market, by Usage, 2017 – 2027
4.03.05 U.S.
4.3.5.1 U.S. Breast Lesion Localization Methods Market, by Type, 2017 – 2027
4.3.5.2 U.S. Breast Lesion Localization Methods Market, by Usage, 2017 – 2027
4.03.06 Canada
4.3.6.1 Canada Breast Lesion Localization Methods Market, by Type, 2017 – 2027
4.3.6.2 Canada Breast Lesion Localization Methods Market, by Usage, 2017 – 2027
4.03.07 Mexico
4.3.7.1 Mexico Breast Lesion Localization Methods Market, by Type, 2017 – 2027
4.3.7.2 Mexico Breast Lesion Localization Methods Market, by Usage, 2017 – 2027
9.36.00 Europe
4.04.01 Europe Breast Lesion Localization Methods Market, 2017 – 2027 (USD Million)
4.04.02 Europe Breast Lesion Localization Methods Market, by Country, 2017 – 2027 (USD Million)
4.04.03 Europe Breast Lesion Localization Methods Market, by Type, 2017 – 2027
4.04.04 Europe Breast Lesion Localization Methods Market, by Usage, 2017 – 2027
4.4.4.1 Germany Breast Lesion Localization Methods Market, by Type, 2017 – 2027
4.4.4.2 Germany Breast Lesion Localization Methods Market, by Usage, 2017 – 2027
4.04.05 France
4.4.5.1 France Breast Lesion Localization Methods Market, by Type, 2017 – 2027
4.4.5.2 France Breast Lesion Localization Methods Market, by Usage, 2017 – 2027
4.04.06 UK
4.4.6.1 UK Breast Lesion Localization Methods Market, by Type, 2017 – 2027
4.4.6.2 UK Breast Lesion Localization Methods Market, by Usage, 2017 – 2027
4.04.07 Italy
4.4.7.1 Italy Breast Lesion Localization Methods Market, by Type, 2017 – 2027
4.4.7.2 Italy Breast Lesion Localization Methods Market, by Usage, 2017 – 2027
4.04.08 Spain
4.4.8.1 Spain Breast Lesion Localization Methods Market, by Type, 2017 – 2027
4.4.8.2 Spain Breast Lesion Localization Methods Market, by Usage, 2017 – 2027
4.04.09 Rest of Europe
4.4.9.1 Rest of Europe Breast Lesion Localization Methods Market, by Type, 2017 – 2027
4.4.9.2 Rest of Europe Breast Lesion Localization Methods Market, by Usage, 2017 – 2027
12.00.00 Asia Pacific
4.05.01 Asia Pacific Breast Lesion Localization Methods Market, 2017 – 2027 (USD Million)
4.05.02 Asia Pacific Breast Lesion Localization Methods Market, by Country, 2017 – 2027 (USD Million)
4.05.03 Asia Pacific Breast Lesion Localization Methods Market, by Type, 2017 – 2027
4.05.04 Asia Pacific Breast Lesion Localization Methods Market, by Usage, 2017 – 2027
4.05.05 China
4.5.5.1 China Breast Lesion Localization Methods Market, by Type, 2017 – 2027
4.5.5.2 China Breast Lesion Localization Methods Market, by Usage, 2017 – 2027
4.05.06 India
4.5.6.1 India Breast Lesion Localization Methods Market, by Type, 2017 – 2027
4.5.6.2 India Breast Lesion Localization Methods Market, by Usage, 2017 – 2027
4.05.07 Japan
4.5.7.1 Japan Breast Lesion Localization Methods Market, by Type, 2017 – 2027
4.5.7.2 Japan Breast Lesion Localization Methods Market, by Usage, 2017 – 2027
4.05.08 Southeast Asia
4.5.8.1 Southeast Asia Breast Lesion Localization Methods Market, by Type, 2017 – 2027
4.5.8.2 Southeast Asia Breast Lesion Localization Methods Market, by Usage, 2017 – 2027
4.05.09 Korea
4.5.9.1 Korea Breast Lesion Localization Methods Market, by Type, 2017 – 2027
4.5.9.2 Korea Breast Lesion Localization Methods Market, by Usage, 2017 – 2027
4.05.10 Australia
4.5.10.1 Australia Breast Lesion Localization Methods Market, by Type, 2017 – 2027
4.5.10.2 Australia Breast Lesion Localization Methods Market, by Usage, 2017 – 2027
4.05.11 Rest of Asia Pacific
4.5.11.1 Rest of Asia Pacific Breast Lesion Localization Methods Market, by Type, 2017 – 2027
4.5.11.2 Rest of Asia Pacific Breast Lesion Localization Methods Market, by Usage, 2017 – 2027
14.24.00 South America and MEA
4.06.01 South America and MEA Breast Lesion Localization Methods Market, 2017 – 2027 (USD Million)
4.06.02 South America and MEA Breast Lesion Localization Methods Market, by Country, 2017 – 2027 (USD Million)
4.06.03 South America and MEA Breast Lesion Localization Methods Market, by Type, 2017 – 2027
4.06.04 South America and MEA Breast Lesion Localization Methods Market, by Usage, 2017 – 2027
4.06.05 MEA
4.6.5.1 MEA Breast Lesion Localization Methods Market, by Type, 2017 – 2027
4.6.5.2 MEA Breast Lesion Localization Methods Market, by Usage, 2017 – 2027
4.06.06 Brazil
4.6.6.1 Brazil Breast Lesion Localization Methods Market, by Type, 2017 – 2027
4.6.6.2 Brazil Breast Lesion Localization Methods Market, by Usage, 2017 – 2027
4.06.07 Rest of SAMEA
4.6.7.1 Rest of SAMEA Breast Lesion Localization Methods Market, by Type, 2017 – 2027
4.6.7.2 Rest of SAMEA Breast Lesion Localization Methods Market, by Usage, 2017 – 2027
0.00.00 Company Profiles
2.24.00 Hologic Inc
5.01.01 Company Overview
5.01.02 Product Portfolio
5.01.03 Financial Performance (USD Million)
5.01.04 Recent Development
4.48.00 Mermaid Medical A/S
5.02.01 Company Overview
5.02.02 Product Portfolio
7.12.00 IZI Medical Products
5.03.01 Company Overview
5.03.02 Product Portfolio
5.4 Matek Medical
5.04.01 Company Overview
5.04.02 Product Portfolio
12.00.00 Tsunami Medical
5.05.01 Company Overview
5.05.02 Product Portfolio
14.24.00 BPB Medica
5.06.01 Company Overview
5.06.02 Product Portfolio
16.48.00 Molli Surgical
5.07.01 Company Overview
5.07.02 Product Portfolio
19.12.00 Argon Medical Devices
5.08.01 Company Overview
5.08.02 Product Portfolio
21.36.00 B.D.
5.09.01 Company Overview
5.09.02 Product Portfolio
5.09.03 Financial Performance (USD Million)
2.24.00 Cianna Medical
5.10.01 Company Overview
5.10.02 Product Portfolio
5.11 Endomag
5.11.01 Company Overview
5.11.02 Product Portfolio
2.52.48 ISOAID
5.12.01 Company Overview
5.12.02 Product Portfolio
3.07.12 Leica Biosystems
5.13.01 Company Overview
5.13.02 Product Portfolio
3.21.36 Surgiceye
5.14.01 Company Overview
5.14.02 Product Portfolio
3.36.00 Ranfac Corporation
5.15.01 Company Overview
5.15.02 Product Portfolio
5.16 Leica Biosystems
5.16.01 Company Overview
5.16.02 Product Portfolio
0.00.00 Breast Lesion Localization Methods — Industry Analysis
6.1 Breast Lesion Localization Methods Market – Key Trends
6.01.01 Market Drivers
6.1.1.1 Increasing Prevalence of Breast Cancer
6.1.1.2 Rapidly Increasing penetration of Health Insurance
6.01.02 Market Restraints
6.1.2.1 Shortage of Skilled Oncologists and Limited Healthcare Infrastructure
6.01.03 Market Opportunities
6.01.04 Developing economies to offer lucrative growth opportunity
4.48.00 Porter’s Five Forces Analysis
6.02.01 Bargaining Power of Suppliers
6.02.02 Bargaining Power of Buyers
6.02.03 Threat of Substitute
6.02.04 Threat of New Entrants
6.02.05 Competitive Rivalry
7.12.00 PESTLE Analysis
9.36.00 Breast Cancer Rate

Tables and Figures

List of Tables
TABLE 1 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2017 – 2027 (USD MILLION)
TABLE 2 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, 2017 – 2027 (USD MILLION)
TABLE 3 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET, BY REGION, 2017 – 2027 (USD MILLION)
TABLE 4 NORTH AMERICA BREAST LESION LOCALIZATION METHODS MARKET, BY COUNTRY, 2017 – 2027 (USD MILLION)
TABLE 5 NORTH AMERICA BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2017 – 2027 (USD MILLION)
TABLE 6 NORTH AMERICA BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, 2017 – 2027 (USD MILLION)
TABLE 7 U.S. BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2017 – 2027 (USD MILLION)
TABLE 8 U.S. BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, 2017 – 2027 (USD MILLION)
TABLE 9 CANADA BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2017 – 2027 (USD MILLION)
TABLE 10 CANADA BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, 2017 – 2027 (USD MILLION)
TABLE 11 MEXICO BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2017 – 2027 (USD MILLION)
TABLE 12 MEXICO BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, 2017 – 2027 (USD MILLION)
TABLE 13 EUROPE BREAST LESION LOCALIZATION METHODS MARKET, BY COUNTRY, 2017 – 2027 (USD MILLION)
TABLE 14 EUROPE BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2017 – 2027 (USD MILLION)
TABLE 15 EUROPE BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, 2017 – 2027 (USD MILLION)
TABLE 16 GERMANY BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2017 – 2027 (USD MILLION)
TABLE 17 GERMANY BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, 2017 – 2027 (USD MILLION)
TABLE 18 FRANCE BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2017 – 2027 (USD MILLION)
TABLE 19 FRANCE BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, 2017 – 2027 (USD MILLION)
TABLE 20 UK BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2017 – 2027 (USD MILLION)
TABLE 21 UK BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, 2017 – 2027 (USD MILLION)
TABLE 22 ITALY BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2017 – 2027 (USD MILLION)
TABLE 23 ITALY BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, 2017 – 2027 (USD MILLION)
TABLE 24 SPAIN BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2017 – 2027 (USD MILLION)
TABLE 25 SPAIN BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, 2017 – 2027 (USD MILLION)
TABLE 26 REST OF EUROPE BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2017 – 2027 (USD MILLION)
TABLE 27 REST OF EUROPE BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, 2017 – 2027 (USD MILLION)
TABLE 28 ASIA PACIFIC BREAST LESION LOCALIZATION METHODS MARKET, BY COUNTRY, 2017 – 2027 (USD MILLION)
TABLE 29 ASIA PACIFIC BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2017 – 2027 (USD MILLION)
TABLE 30 ASIA PACIFIC BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, 2017 – 2027 (USD MILLION)
TABLE 31 CHINA BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2017 – 2027 (USD MILLION)
TABLE 32 CHINA BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, 2017 – 2027 (USD MILLION)
TABLE 33 INDIA BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2017 – 2027 (USD MILLION)
TABLE 34 INDIA BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, 2017 – 2027 (USD MILLION)
TABLE 35 JAPAN BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2017 – 2027 (USD MILLION)
TABLE 36 JAPAN BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, 2017 – 2027 (USD MILLION)
TABLE 37 SOUTHEAST ASIA BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2017 – 2027 (USD MILLION)
TABLE 38 SOUTHEAST ASIA BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, 2017 – 2027 (USD MILLION)
TABLE 39 KOREA BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2017 – 2027 (USD MILLION)
TABLE 40 KOREA BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, 2017 – 2027 (USD MILLION)
TABLE 41 AUSTRALIA BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2017 – 2027 (USD MILLION)
TABLE 42 AUSTRALIA BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, 2017 – 2027 (USD MILLION)
TABLE 43 REST OF ASIA PACIFIC BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2017 – 2027 (USD MILLION)
TABLE 44 REST OF ASIA PACIFIC BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, 2017 – 2027 (USD MILLION)
TABLE 45 SOUTH AMERICA AND MEA BREAST LESION LOCALIZATION METHODS MARKET, BY COUNTRY, 2017 – 2027 (USD MILLION)
TABLE 46 SOUTH AMERICA AND MEA BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2017 – 2027 (USD MILLION)
TABLE 47 SOUTH AMERICA AND MEA BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, 2017 – 2027 (USD MILLION)
TABLE 48 MEA BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2017 – 2027 (USD MILLION)
TABLE 49 MEA BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, 2017 – 2027 (USD MILLION)
TABLE 50 BRAZIL BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2017 – 2027 (USD MILLION)
TABLE 51 BRAZIL BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, 2017 – 2027 (USD MILLION)
TABLE 52 REST OF SAMEA BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2017 – 2027 (USD MILLION)
TABLE 53 REST OF SAMEA BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, 2017 – 2027 (USD MILLION)
TABLE 54 MARKET DRIVERS – IMPACT ANALYSIS
TABLE 55 MARKET RESTRAINTS
List of Figures
FIGURE 1 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET, 2017 – 2027 (USD MILLION)
FIGURE 2 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SHARE, BY TYPE, 2020 & 2029 (USD MILLION)
FIGURE 3 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET FOR WIRE LOCALIZATION, 2017 – 2027 (USD MILLION)
FIGURE 4 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET FOR RADIOISOTOPE LOCALIZATION, 2017 – 2027 (USD MILLION)
FIGURE 5 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET FOR MAGNETIC LOCALIZATION, 2017 – 2027 (USD MILLION)
FIGURE 6 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET FOR OTHERS, 2017 – 2027 (USD MILLION)
FIGURE 7 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SHARE, BY USAGE, 2020 & 2029 (USD MILLION)
FIGURE 8 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET FOR TUMOR IDENTIFICATION, 2017 – 2027 (USD MILLION)
FIGURE 9 GLOBAL SENTINEL LYMPH NODE IDENTIFICATION BREAST LESION LOCALIZATION METHODS MARKET, 2017 – 2027 (USD MILLION)
FIGURE 10 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SHARE, BY REGION, 2020 & 2029 (%)
FIGURE 11 NORTH AMERICA BREAST LESION LOCALIZATION METHODS MARKET, 2017 – 2027 (USD MILLION)
FIGURE 12 EUROPE BREAST LESION LOCALIZATION METHODS MARKET, 2017 – 2027 (USD MILLION)
FIGURE 13 ASIA PACIFIC BREAST LESION LOCALIZATION METHODS MARKET, 2017 – 2027 (USD MILLION)
FIGURE 14 SOUTH AMERICA AND MEA BREAST LESION LOCALIZATION METHODS MARKET, 2017 – 2027 (USD MILLION)

Frequently Asked Questions

  • How is wire localization implemented?

    To help surgeons locate a breast anomaly, a small wire is inserted into the breast tissue. This procedure is known as wire localization. Before surgery, the wire is usually inserted using imaging guidance, such as ultrasonography or mammography.
  • What benefits can wire-free localization techniques offer?

    Compared to traditional wire localization, wire-free methods like RSL, MSL, and RFID have a number of benefits, such as less patient discomfort, increased accuracy, shorter localization-to-surgery intervals, and the removal of the need for a protruding wire, which can cause discomfort for patients.
  • Is localizing a breast lesion painful?

    The technique employed and certain patient characteristics may have an impact on the level of discomfort related to breast lesion localization. Conventional wire localization techniques can be painful or uncomfortable when the wire is inserted, while wire-free techniques are typically less intrusive and more comfortable for patients.